TSTuleen Sawaf

Tuleen Sawaf

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tuleen Sawaf has a total of 36 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Validity of Activity-Based Checks (ABCs) of Pain, A Functional Pain Scale

    by Celina G. Virgen, Robert Wright, Bryan Renslo, Tuleen Sawaf, Hanna Moradi, Maria Edelen, Jennifer Villwock


  • Outcomes of Microvascular Free Flap Reconstruction With One Versus Two Primary Surgeons

    by Jamison Macke, Tuleen Sawaf, Natalie Schelbar, Bryan Renslo, Heather Schopper, Kevin J. Sykes, Andres Bur, Justin Bond, Yelizaveta Shnayder, Terance T. Tsue, et al.

    Objective: To evaluate operative efficiency and quality in head and neck free flap reconstruction with one versus two primary surgeons by comparing procedure duration, hospital length of stay, complications and readmission rates.Study Design: Retrospective chart review.Setting: Single‐institution tertiary care centre.Methods: A total of 583 patients who received head and neck surgery with free flap reconstruction at the University of Kansas Medical Center between November 2010 and January 2021 were stratified into two cohorts: one‐surgeon cohort and two‐surgeon cohort. In the two‐surgeon cohort, one surgeon performed tissue resection and the second performed reconstruction (n = 329), whereas one primary surgeon performed both resection and reconstruction in the one‐surgeon cohort (n = 254). Patient age, sex, American Society of Anaesthesia (ASA) status and Charlson comorbidity index (CCI) at time of surgery were collected.Results: No significant difference in baseline clinicodemographic characteristics was found between groups. A reduced mean procedure duration was found in the one‐surgeon cohort (424.9 min, SD 127.6) compared to the two‐surgeon cohort (552.4 min, SD 119.2) (mean difference 127.5 min, Cohen d = 1.04). A slightly greater proportion of osteocutaneous free flaps was performed in the two‐surgeon cohort compared to the one‐surgeon cohort (one‐surgeon: 53.5%; two‐surgeon 62.3%). All other secondary quality measures showed nonsignificant differences with the exception of the proportion requiring intraoperative pressors (86.2% in one‐surgeon cohort vs. 74.5% in two‐surgeon cohort, mean difference 11.7%, Cohen d = 0.29).Conclusions: This study demonstrates at least noninferior efficiency and quality outcomes in free flap cases led by single primary surgeons at our institution. The optimal approach to maximise operative efficiency and quality likely differs across surgeons and centres.Level of Evidence: III.


  • Functional Oral Intake in Primary Versus Salvage Laryngectomy

    by Anna C. Lawrence, Sarah King, Bryan Renslo, Tuleen Sawaf, Omar Karadaghy, Shannon Kraft

    Objective: Advanced‐stage laryngeal squamous cell carcinoma is treated with primary surgery or chemoradiation. We aim to determine if there are differences in postoperative functional oral intake in primary (PL) versus salvage laryngectomees (SL).Study Design: Retrospective cohort study.Setting: Patients who underwent laryngectomy between 2011 and 2021.Methods: We examined demographic, diagnostic, treatment, and swallow function data pre‐ and postoperatively. A follow‐up survey was distributed to assess current swallow status.Results: One hundred twenty‐five patients were included. Preoperatively, 68.8% of patients reported dysphagia. Median functional oral intake score (FOIS) was 4.0 [interquartile range, IQR: 1.0‐6.75]. The SL group had lower preop FOIS [2.0; IQR: 1.0‐4.75] that did not reach significance compared to the PL group [4.5; IQR: 1.0‐7.0] (P = .052). 73.4% of patients had a feeding tube. The PL group was more likely to have the tube removed [odds ratio, OR: 2.4; confidence interval, CI: 1.0‐5.7]. The SL group was more likely to require feeding tube placement more than 6 months postop [OR: 6.9; CI: 1.65‐32.6]. SL FOIS scores improved by 3 months postop to 5 (SL ΔFOIS = 3, P = .0150). PL scores improved to 7 [PL ΔFOIS = 2, P = .0005] at 12 to 15 months. Sixty‐nine patients were contacted for a follow‐up survey and 16 completed this survey. 30.4% patients reported dietary restrictions (mean 4.4 years postop).Conclusion: Patients undergoing SL appear to obtain similar swallow outcomes compared to PL at 3 to 6 months postlaryngectomy, but plateau. The PL group continues to improve up to 1 year postoperatively. Fifty percent of patients report on‐going dysphagia after 5 years.


  • Open Access

    Loss to Follow‐up in Head and Neck Cancer: A Systematic Review of Randomized Controlled Trials

    by Tuleen Sawaf, Brooke A. Quinton, Gabriel Moss, Noah M. Yaffe, Humzah A. Quereshy, Claudia Cabrera‐Aviles, Nicole Fowler, Shawn Li, Jason E. Thuener, Pierre Lavertu, et al.

    Objective: To evaluate the reporting and rates of loss to follow‐up (LTFU) in head and neck cancer (HNC) randomized controlled trials based in the United States.Data Sources: Pubmed/MEDLINE, Cochrane, Scopus databases.Review Methods: A systematic review of titles in Pubmed/MEDLINE, Scopus, and Cochrane Library was performed. Inclusion criteria were US‐based randomized controlled trials focused on the diagnosis, treatment, or prevention of HNC. Retrospective analyses and pilot studies were excluded. The mean age, patients randomized, publication details, trial sites, funding, and LTFU data were recorded. Reporting of participants through each stage of the trial was documented. Binary logistic regression was performed to evaluate associations between study characteristics and reporting LTFU.Results: A total of 3255 titles were reviewed. Of these, 128 studies met the inclusion criteria for analysis. A total of 22,016 patients were randomized. The mean age of participants was 58.6 years. Overall, 35 studies (27.3%) reported LTFU, and the mean LTFU rate was 4.37%. With the exception of 2 statistical outliers, study characteristics including publication year, number of trial sites, journal discipline, funding source, and intervention type did not predict the odds of reporting LTFU. Compared to 95% of trials reporting participants at eligibility and 100% reporting randomization, only 47% and 57% reported on withdrawal and details of the analysis, respectively.Conclusion: The majority of clinical trials in HNC in the United States do not report LTFU, which inhibits the evaluation of attrition bias that may impact the interpretation of significant findings. Standardized reporting is needed to evaluate the generalizability of trial results to clinical practice.